Filing Details
- Accession Number:
- 0001127602-19-034630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-09 19:27:02
- Reporting Period:
- 2019-12-06
- Accepted Time:
- 2019-12-09 19:27:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643746 | H. Lorence Kim | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-06 | 229,357 | $20.64 | 1,371,684 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-12-06 | 229,358 | $20.64 | 1,601,042 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-12-06 | 89,698 | $19.34 | 1,511,344 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-06 | 147,528 | $20.39 | 1,363,816 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-06 | 1,306 | $20.93 | 1,362,510 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2019-12-06 | 229,357 | $0.00 | 229,357 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2019-12-06 | 229,358 | $0.00 | 229,358 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018, and amended on September 17, 2019. The sale was made to generate proceeds to cover the tax liability incident to the delivery of restricted stock units.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.86 to $19.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.87 to $20.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.92 to $20.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These Restricted Stock Units are fully vested and settled in accordance with their terms.